中国临床营养杂志
中國臨床營養雜誌
중국림상영양잡지
CHINESE JOURNAL OF CLINICAL NUTRITION
2009年
1期
32-36
,共5页
刘英华%薛长勇%郑子新%于晓明%张永%王觐%张月红%景洪江
劉英華%薛長勇%鄭子新%于曉明%張永%王覲%張月紅%景洪江
류영화%설장용%정자신%우효명%장영%왕근%장월홍%경홍강
中链脂肪酸%长链脂肪酸%甘油三酯%高脂血症%脂蛋白
中鏈脂肪痠%長鏈脂肪痠%甘油三酯%高脂血癥%脂蛋白
중련지방산%장련지방산%감유삼지%고지혈증%지단백
Medium-chain fatty acid%Long-chain fatty acid%Triglycerides%Hyperlipemia%Lipoprotein
目的 研究中长链脂肪酸食用油对高甘油三酯血症患者血脂及脂蛋白水平的影响.方法 采用临床随机对照法,按随机原则将112例高甘油三酯血症患者分为中长链脂肪酸食用油组和长链脂肪酸食用油组,控制每日膳食摄入量及食用油摄人量(25~30 g/d),推荐每日运动量,分别在研究开始前和8周后,检测两组研究对象的身高、体重、空腹血糖,血清丙氨酰氨基转移酶(ALT)、天冬氨酰氨基转移酶(AST)、总胆固醇、甘油三酯、高密度脂蛋白胆固醇,低密度脂蛋白胆固醇,载脂蛋白Al(ApoAl)、载脂蛋白B(ApoB)、载脂蛋白AⅡ(ApoAⅡ)、载脂蛋白C2(ApoC2)、载脂蛋白C3(ApoC3)及载脂蛋白E(ApoE).结果 进入结果分析者101例,其中长链脂肪酸食用油组50例,中长链脂肪酸食用油组51例.研究开始时两组的体重、血清ALT、AST、总胆固醇、甘油三酯等生化指标的差异均无统计学意义(P>0.05).食用中长链脂肪酸食用油8周后,患者的体重及血清甘油三酯、ApoC2、ApoC3水平均显著低于研究开始时(P<0.05),而ApoAl显著高于研究开始时(P<0.05).研究结束时,中长链脂肪酸食用油组的体重、血清甘油三酯、ApoB、ApoAⅡ、ApoC2及ApoC3水平均显著低于长链脂肪酸食用油组(P<0.05).结论 合理膳食条件下,中长链脂肪酸食用油可降低高甘油三酯血症患者血脂浓度,改善脂蛋白水平.
目的 研究中長鏈脂肪痠食用油對高甘油三酯血癥患者血脂及脂蛋白水平的影響.方法 採用臨床隨機對照法,按隨機原則將112例高甘油三酯血癥患者分為中長鏈脂肪痠食用油組和長鏈脂肪痠食用油組,控製每日膳食攝入量及食用油攝人量(25~30 g/d),推薦每日運動量,分彆在研究開始前和8週後,檢測兩組研究對象的身高、體重、空腹血糖,血清丙氨酰氨基轉移酶(ALT)、天鼕氨酰氨基轉移酶(AST)、總膽固醇、甘油三酯、高密度脂蛋白膽固醇,低密度脂蛋白膽固醇,載脂蛋白Al(ApoAl)、載脂蛋白B(ApoB)、載脂蛋白AⅡ(ApoAⅡ)、載脂蛋白C2(ApoC2)、載脂蛋白C3(ApoC3)及載脂蛋白E(ApoE).結果 進入結果分析者101例,其中長鏈脂肪痠食用油組50例,中長鏈脂肪痠食用油組51例.研究開始時兩組的體重、血清ALT、AST、總膽固醇、甘油三酯等生化指標的差異均無統計學意義(P>0.05).食用中長鏈脂肪痠食用油8週後,患者的體重及血清甘油三酯、ApoC2、ApoC3水平均顯著低于研究開始時(P<0.05),而ApoAl顯著高于研究開始時(P<0.05).研究結束時,中長鏈脂肪痠食用油組的體重、血清甘油三酯、ApoB、ApoAⅡ、ApoC2及ApoC3水平均顯著低于長鏈脂肪痠食用油組(P<0.05).結論 閤理膳食條件下,中長鏈脂肪痠食用油可降低高甘油三酯血癥患者血脂濃度,改善脂蛋白水平.
목적 연구중장련지방산식용유대고감유삼지혈증환자혈지급지단백수평적영향.방법 채용림상수궤대조법,안수궤원칙장112례고감유삼지혈증환자분위중장련지방산식용유조화장련지방산식용유조,공제매일선식섭입량급식용유섭인량(25~30 g/d),추천매일운동량,분별재연구개시전화8주후,검측량조연구대상적신고、체중、공복혈당,혈청병안선안기전이매(ALT)、천동안선안기전이매(AST)、총담고순、감유삼지、고밀도지단백담고순,저밀도지단백담고순,재지단백Al(ApoAl)、재지단백B(ApoB)、재지단백AⅡ(ApoAⅡ)、재지단백C2(ApoC2)、재지단백C3(ApoC3)급재지단백E(ApoE).결과 진입결과분석자101례,기중장련지방산식용유조50례,중장련지방산식용유조51례.연구개시시량조적체중、혈청ALT、AST、총담고순、감유삼지등생화지표적차이균무통계학의의(P>0.05).식용중장련지방산식용유8주후,환자적체중급혈청감유삼지、ApoC2、ApoC3수평균현저저우연구개시시(P<0.05),이ApoAl현저고우연구개시시(P<0.05).연구결속시,중장련지방산식용유조적체중、혈청감유삼지、ApoB、ApoAⅡ、ApoC2급ApoC3수평균현저저우장련지방산식용유조(P<0.05).결론 합리선식조건하,중장련지방산식용유가강저고감유삼지혈증환자혈지농도,개선지단백수평.
Objective To investigate the effect of oil with medium-long-chain triacylglycerols on blood lip- id and lipoproteins in hyperlipemic patients. Methods Totally, 112 patients with hypertriglyceridemia were en- rolled and randomly divided into MLCT group (consumed oil with medium-long-chain fatty acids) and LCT group (consumed oil with long-chain fatty acids) (both 25-30 g/d for 8 weeks). Patients in both two groups were also instructed to take exercises. Height and weight were measured at baseline and 8 weeks later. Blood glucose, serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total cholesterols (TC), triglyc- erides (TG), high density lipoprotein cholesterol, low density lipoprotein cholesterol, apolipoprotein Al (ApoAl), ApoB, ApoA II , ApoC2, ApoC3, and ApoE were measured and compared. Results At the end of study, 101 subjects were included. There were 50 subjects left in LCT group and 51 subjects left in MLCT group, respectively. There was no significant difference in weight, ALT, AST, TC, and TG at baseline between two groups (P>0.05). Eight weeks later, weight, serum TG, ApoC2, and ApoC3 were significantly lower and ApoAl level was significantly higher than those at baseline in MLCT group (P < 0.05). At the end of study, the decreases in body weight and blood biochemical variables including TG, ApoB, ApoA II , ApoC2, ApoC3 were significantly much greater in MLCT groups than those in LCT group (P < 0. 05). Conclusion When the diet is reasonably controlled, oil of medium-long-chain triacylglycerols may reduce the concentration of TG and improve the levels of apolipoproteins.